DCGI approves Phase II/III clinical trial of Covaxin in age group 2 to 18 yrs ...Middle East

Devdiscourse - Opinion
DCGI approves Phase II/III clinical trial of Covaxin in age group 2 to 18 yrs
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of the Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021.

Hence then, the article about dcgi approves phase ii iii clinical trial of covaxin in age group 2 to 18 yrs was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( DCGI approves Phase II/III clinical trial of Covaxin in age group 2 to 18 yrs )

Apple Storegoogle play

Last updated :

Also on site :



Latest News